Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ANNX · against 481 other Healthcare companies of similar size
Ranked #323 of 482 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score160 peers with a valuation score of 0–9, including ANNX · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | ANNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 470 reported | -27.0% | 1.2% | 6% | 30% | |
| EBITDA yieldHigher is better · 488 reported | -34.2% | 4.1% | 5% | 50% | |
| Free cash flow yieldHigher is better · 196 reported | -24.3% | -2.7% | 6% | 20% | |
| Book yieldHigher is better · 479 reported | 25.4% | 42.9% | 25% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 323 | 551M USD | 8 | 20 | |
| 323 | 1.5B USD | 8 | 26 | |
| 323 | 831M USD | 8 | ||
| 323 | 841M USD | 8 | 33 | |
| 323 | 794M USD | 8 | ||
| 323 | 891M USD | 8 | ||
| 323 | 487M USD | 8 | 24 | |
| 323 | 782M USD | 8 | 35 | |
| 323 | 647M USD | 8 | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score